R P Perng Selected Research

Epirubicin (Ellence)

8/2000	Combination chemotherapy with tamoxifen, ifosfamide, epirubicin and cisplatin in extensive-disease small-cell lung cancer.
8/2000	Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy.
2/2000	A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R P Perng Research Topics

Disease

10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2002 - 02/2000
7	Neoplasms (Cancer) 01/2002 - 01/2000
5	Malignant Pleural Effusion 01/2002 - 01/2000
4	Pleural Effusion (Pleural Effusions) 01/2002 - 09/2000
2	Tuberculosis (Tuberculoses) 12/2001 - 04/2001
2	Infections 12/2001 - 04/2001
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2000 - 07/2000
1	Pulmonary Tuberculosis 11/2002
1	Inflammation (Inflammations) 12/2001
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 11/2001
1	Pneumonia (Pneumonitis) 11/2001
1	Abscess 04/2001
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 04/2001
1	Suppuration 04/2001
1	Hepatocellular Carcinoma (Hepatoma) 03/2001
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2001
1	Neoplasm Metastasis (Metastasis) 03/2001
1	Pancoast Syndrome 03/2001
1	Hepatic Encephalopathy 02/2001
1	Lung Neoplasms (Lung Cancer) 01/2001
1	Pleurisy (Pleuritis) 01/2001
1	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2000

Drug/Important Bio-Agent (IBA)

7	Cisplatin (Platino)FDA LinkGeneric 12/2000 - 02/2000
4	Ifosfamide FDA LinkGeneric 12/2000 - 02/2000
3	CytokinesIBA 01/2002 - 01/2001
3	Gemcitabine FDA Link 01/2002 - 06/2000
3	Interleukin-2 (IL2)IBA 01/2002 - 01/2000
3	Docetaxel (Taxotere)FDA Link 11/2001 - 10/2000
3	Epirubicin (Ellence)FDA LinkGeneric 08/2000 - 02/2000
3	Tamoxifen FDA LinkGeneric 08/2000 - 02/2000
2	Interleukin-12 (IL 12)IBA 01/2002 - 04/2001
2	Interferon-gamma (Interferon, gamma)IBA 04/2001 - 01/2001
2	Vinorelbine (Navelbine)FDA LinkGeneric 06/2000 - 02/2000
1	rifampin drug combination pyrazinamide isoniazid FDA Link 11/2002
1	Interleukin-18 (Interleukin 18)IBA 01/2002
1	Fas Ligand Protein (Fas Ligand)IBA 01/2002
1	Carboplatin (JM8)FDA LinkGeneric 01/2002
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2002
1	AcidsIBA 12/2001
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2001
1	Interleukin-7 (Interleukin 7)IBA 04/2001
1	VaccinesIBA 04/2001
1	Pyrazinamide FDA LinkGeneric 04/2001
1	Isoniazid (Ftivazide)FDA LinkGeneric 04/2001
1	Rifampin (Rifampicin)FDA LinkGeneric 04/2001
1	Ethambutol (Myambutol)FDA LinkGeneric 04/2001
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 03/2001
1	Interleukin-10 (Interleukin 10)IBA 01/2001
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2001
1	SteroidsIBA 06/2000
1	ErbB Receptors (EGF Receptor)IBA 02/2000
1	Interleukin-15 (Interleukin 15)IBA 01/2000

Therapy/Procedure

8	Combination Drug Therapy (Combination Chemotherapy) 11/2002 - 02/2000
6	Drug Therapy (Chemotherapy) 10/2000 - 02/2000
2	Therapeutics 11/2001 - 04/2001
1	Artificial Respiration (Mechanical Ventilation) 11/2001
1	Pleurodesis 09/2000
1	Catheters 09/2000
1	Radiotherapy 06/2000